» Articles » PMID: 8231659

Higher Levels of Plasma Cholesterol Sulfate in Patients with Liver Cirrhosis and Hypercholesterolemia

Overview
Journal Lipids
Specialty Biochemistry
Date 1993 Sep 1
PMID 8231659
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

An analytical method for the determination of cholesterol sulfate (CS) in plasma using gas-liquid chromatography was developed. We measured plasma CS concentrations in patients with liver cirrhosis and hypercholesterolemia as examples of disorders that involve aberrations in cholesterol metabolism. Patients with liver cirrhosis had plasma CS concentrations that were significantly higher than those of control subjects (444.6 +/- 51.7 vs. 253.0 +/- 24.6 micrograms/dL, mean +/- SE). The levels of other lipids were lower in cirrhotics, although the differences were not significant. There was no correlation between the levels of CS and sulfated bile acids in cirrhotic patients. CS levels in plasma were also higher in subjects with hypercholesterolemia (413.7 +/- 44.5 micrograms/dL); however, the ratio of CS to total cholesterol (TC) clearly differed between cirrhotics and hypercholesterolemic subjects (1.44 +/- 0.11 x 10(-3) vs. 3.31 +/- 0.63 x 10(-3); P < 0.05). Both in subjects with hypercholesterolemia and in healthy controls, the CS/TC ratio was similar and CS accounted for roughly 0.14% of the TC concentration.

Citing Articles

Revisiting the effect of cholesteryl sulfate on clotting and fibrinolysis: Inhibition of human thrombin and other human blood proteases.

Al-Horani R Heliyon. 2024; 10(6):e28017.

PMID: 38533078 PMC: 10963326. DOI: 10.1016/j.heliyon.2024.e28017.


The Immunosuppressive Potential of Cholesterol Sulfate Through T Cell Microvilli Disruption.

Park J, Chung I, Kim H, Jun C Immune Netw. 2023; 23(3):e29.

PMID: 37416932 PMC: 10320417. DOI: 10.4110/in.2023.23.e29.


Metabolomics and Lipidomics Signatures of Insulin Resistance and Abdominal Fat Depots in People Living with Obesity.

Koay Y, Coster A, Chen D, Milner B, Batarseh A, OSullivan J Metabolites. 2022; 12(12).

PMID: 36557310 PMC: 9781703. DOI: 10.3390/metabo12121272.


Common structural features of cholesterol binding sites in crystallized soluble proteins.

Bukiya A, Dopico A J Lipid Res. 2017; 58(6):1044-1054.

PMID: 28420706 PMC: 5454519. DOI: 10.1194/jlr.R073452.


Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.

Lau S, Lee K, Curreem S, Chow W, To K, Hung I J Clin Microbiol. 2015; 53(12):3750-9.

PMID: 26378277 PMC: 4652110. DOI: 10.1128/JCM.01568-15.


References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Iwamori M, Moser H, Kishimoto Y . Cholesterol sulfate in rat tissues. Tissue distribution, developmental change and brain subcellular localization. Biochim Biophys Acta. 1976; 441(2):268-79. DOI: 10.1016/0005-2760(76)90170-3. View

3.
Lalumiere G, Bleau G, CHAPDELAINE A, Roberts K . Cholesteryl sulfate and sterol sulfatase in the human reproductive tract. Steroids. 1976; 27(2):247-60. DOI: 10.1016/0039-128x(76)90101-x. View

4.
DRAYER N, Lieberman S . ISOLATION OF CHOLESTEROL SULFATE FROM HUMAN BLOOD AND GALLSTONES. Biochem Biophys Res Commun. 1965; 18:126-30. DOI: 10.1016/0006-291x(65)90894-6. View

5.
Veares M, Evershed R, Prescott M, Goad L . Quantitative determination of cholesterol sulphate in plasma by stable isotope dilution fast atom bombardment mass spectrometry. Biomed Environ Mass Spectrom. 1990; 19(10):583-8. DOI: 10.1002/bms.1200191002. View